Delivery Order SPE2DB25D3108-SPE2DB25FPDHC
Award Date
7/10/25
Potential Completion Date
7/11/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,238.22 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a medication used to treat diabetes. The contract has an ultimate completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a $3,916.47 delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of the drug Glimepiride 2 mg, which is used to treat diabetes. The contract is a firm fixed-price, non-set-aside contract with a completion date of May 29, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $2,043.05 and a completion date of July 2, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLIMEPIRIDE 2 MG TABLET 100S, a diabetes medication, with a firm fixed price of $1,044.44 and a performance period ending on May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,143,237 units of the diabetes medication Glimepiride 4 mg tablets. The delivery order, valued at $5,993.70, is a firm fixed-price contract with a completion date of May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The contract is part of a larger...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a medication used to treat diabetes. The contract has a firm fixed price of $1,514.54 and a completion date of May 23, 2025. The award is not set-aside and was made on May 22, 2025. Amerisourcebergen Drug Corp is a for-profit organization...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,326.08, is for the delivery of 4,568,142,317 units of the diabetes medication Glimepiride 2 mg tablets. The contract has a period of performance through May 6, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,756.55 and a performance period through June 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a medication used to treat diabetes. The contract has a ceiling value of $22,381.46 and is a firm fixed price contract with a completion date of June 24, 2025. The contract is not set aside for any specific business category....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,826.50 firm fixed-price delivery order contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...